Financials
- Market Capitalization 7.26 B
- Employee 418
- Founded 2018
- CEO N/A
- Website www.mirumpharma.com
- Headquarter Delaware, United States
- FIGI BBG00MH7T2M7
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-168.06
Rapporto prezzo/fatturato
7.61
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1065 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.76% | +53.71% | 7.62 B USD | ||
| 1081 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +15.58% | -2.56% | 7.37 B USD | ||
| 1156 | SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.07% | +82.21% | 6.55 B USD | ||
| 1159 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +29.88% | +66.02% | 6.55 B USD |